KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Neogenomics (NEO) Long-Term Debt Repayments (2016 - 2019)

Neogenomics filings provide 10 years of Long-Term Debt Repayments readings, the most recent being $3.2 million for Q2 2019.

  • On a quarterly basis, Long-Term Debt Repayments rose 329.77% to $3.2 million in Q2 2019 year-over-year; TTM through Sep 2020 was $3.2 million, a 91.01% decrease, with the full-year FY2025 number at $201.2 million, changed N/A from a year prior.
  • Long-Term Debt Repayments hit $3.2 million in Q2 2019 for Neogenomics, up from $1.8 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $54.6 million in Q4 2016 to a low of -$4.1 million in Q4 2017.
  • Median Long-Term Debt Repayments over the past 5 years was $1.3 million (2015), compared with a mean of $5.5 million.
  • Biggest five-year swings in Long-Term Debt Repayments: crashed 303.71% in 2016 and later soared 13214.29% in 2017.
  • Neogenomics' Long-Term Debt Repayments stood at $1.2 million in 2015, then surged by 4437.57% to $54.6 million in 2016, then tumbled by 107.56% to -$4.1 million in 2017, then skyrocketed by 842.27% to $30.6 million in 2018, then plummeted by 89.54% to $3.2 million in 2019.
  • The last three reported values for Long-Term Debt Repayments were $3.2 million (Q2 2019), $1.8 million (Q1 2019), and $30.6 million (Q4 2018) per Business Quant data.